Ezetimibe added to statin results in greater achievement of LDL goals


Ezetimibe added to a stable dose of statin therapy reduces low-densitylipoprotein (LDL) cholesterol by an additional 23% and results in significantlymore patients achieving their LDL cholesterol goals, said Thomas Pearson,MD, MPH, at the 53rd Annual Scientific Session of the American College ofCardiology (ACC) in New Orleans.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.